Keywords: Bayer, Stivarga, Regorafenib, USA, FDA, Sanofi, Zaltrap, GlobalData, Onyx

Bayer's Stivarga races to FDA approval on the heels of Zaltrap

Article | 07 October 2012

Print This

The earlier than expected US Food and Drug Administration approval of German drug major Bayer’s (BAYN: DE) Stivarga ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in